- Scientist - Author -
Robert Tindle.
$99,000: That is the price the directors of pharmaceutical firm WSW set for a single course of its game-changing anti-cancer drug, DELGA, despite the profound moral objections of CEO William Prior.
Upon learning of cancer patients' families torn apart by the tragic consequences of that decision, William succumbs to an overpowering ethical quandary, leading his children, Ben and Samantha, to seek reparation worldwide.
From northern England's slums and religious indoctrination to front-line research institutions worldwide, stem pioneer Robert Tindle's relentless curiosity led him to a remarkable career in fields as disparate as evolutionary biology and immunotherapy for cancer. Following years of fieldwork on the Galapagos Islands, he pioneered breakthroughs in biomedical research in Australia and the United Kingdom.
This book conveys the excitement of scientific discovery and chronicles how his own discoveries were used to save the life of his daughter.
Of the more than 200 human papillomavirus (HPV) types, a handful of sexually transmitted types infect genital and anal skin. Infection may be asymptomatic, but in some cases, progress to warty lesions. In a small proportion of individuals, these lesions progress to premalignant or malignant growths, particularly in the cervix and vagina and the peri-anal skin.
Cervical cancer is the fourth leading cause of cancer death in women globally, until recently claiming the lives of approximately 500,000 women every year.
Vaccines for Human Papillomavirus Infection and Anogenital Disease describes expert studies from leading medical research institutions and hospitals worldwide into the biology of the disease and how the immune system may be manipulated to prevent infection with HPV and to treat HPV-associated disease.
